Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1986 3
1987 2
1988 2
1989 1
1990 2
1992 1
1993 2
1995 1
1997 1
2000 2
2001 2
2004 2
2005 2
2006 2
2007 1
2008 4
2009 2
2010 3
2011 1
2012 5
2013 1
2014 2
2015 3
2016 3
2017 6
2018 2
2019 1
2020 2
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS).
Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Röther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I; ESC Scientific Document Group. Aboyans V, et al. Eur Heart J. 2018 Mar 1;39(9):763-816. doi: 10.1093/eurheartj/ehx095. Eur Heart J. 2018. PMID: 28886620 Free article. No abstract available.
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, Probstfield J, Bhatt DL, Zhu J, Liang Y, Maggioni AP, Lopez-Jaramillo P, O'Donnell M, Kakkar AK, Fox KAA, Parkhomenko AN, Ertl G, Störk S, Keltai M, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Tonkin AM, Lewis BS, Felix C, Yusoff K, Steg PG, Metsarinne KP, Cook Bruns N, Misselwitz F, Chen E, Leong D, Yusuf S; COMPASS Investigators. Eikelboom JW, et al. N Engl J Med. 2017 Oct 5;377(14):1319-1330. doi: 10.1056/NEJMoa1709118. Epub 2017 Aug 27. N Engl J Med. 2017. PMID: 28844192 Free article. Clinical Trial.
Inflammation and vascular diseases.
Karetová D, Bultas J. Karetová D, et al. Vnitr Lek. 2022 Fall;68(5):309-314. doi: 10.36290/vnl.2022.065. Vnitr Lek. 2022. PMID: 36283822 English.
[Angiology is moving forward].
Karetová D. Karetová D. Cas Lek Cesk. 2016;155(4):5-8. Cas Lek Cesk. 2016. PMID: 27481194 Review. Czech.
[Editorial].
Karetová D. Karetová D. Cas Lek Cesk. 2015;154(6):259. Cas Lek Cesk. 2015. PMID: 26785512 Czech. No abstract available.
Fabry disease - Vascular manifestations.
Karetova D, Bultas J, Dostalova G, Palecek T, Kovarnik T, Golan L, Linhart A. Karetova D, et al. Vasa. 2010 May;39(2):123-31. doi: 10.1024/0301-1526/a000017. Vasa. 2010. PMID: 20464667 Review.
Anticoagulant therapy in the elderly.
Karetová D, Bultas J. Karetová D, et al. Vnitr Lek. 2018 Winter;64(11):1011-1020. Vnitr Lek. 2018. PMID: 30606017 English.
Cardiac manifestations in Fabry disease.
Linhart A, Lubanda JC, Palecek T, Bultas J, Karetová D, Ledvinová J, Elleder M, Aschermann M. Linhart A, et al. Among authors: karetova d. J Inherit Metab Dis. 2001;24 Suppl 2:75-83; discussion 65. doi: 10.1023/a:1012428009627. J Inherit Metab Dis. 2001. PMID: 11758683 Review.
61 results